20 May 2026
EU Pharmaceutical Package | Part I – Regulatory Data & Market Protection, Orphan Market Exclusivity, Bolar Exemption and Antimicrobial Vouchers
15 min read
This is our first news alert on the pharmaceutical package, as released in March 2026, addressing four commercially critical areas: (i) regulatory data and market protection; (ii) market exclusivity for orphan medicinal products; (iii) the Bolar exemption; and (iv) the new transferable exclusivity vouchers for priority antimicrobials.
See more via the below note
Attachments:
Key contacts
News & insights
5 min
read
read
Briefings
EU and Mexico Launch High-Level Dialogue on Health: Implications for Life Sciences Companies
5 November 2026
Brussels / Mexico City, 5 November 2026 — Joint client alert by Van Bael & Bellis and Arochi & Lindner
10 min
read
read
Briefings
The EU catch-all clause: why unlisted dual-use goods may still require an export licence
30 October 2026
10 min
read
read
Briefings
Dual-Use Items: AG Backs Broad Test in Case C-538/25
13 October 2026
10 min
read
read
Briefings
China arms embargo: political pledge, real compliance risks
18 November 2026
1 min
read
read
Briefings
EU General Court Ruling on Customs Classification of Split Consignments in EU Assembly Operations
9 October 2026
2 min
read
read
Briefings
Poland – Polish Competition Authority Fines Medicine Wholesalers for Illegally Exchanging Confidential Information
23 September 2026
2 min
read
read
Briefings
Belgian Competition Authority Imposes fine of EUR 29.8 Million on Pharmaceutical Wholesaler Pharma Belgium-Belmedis
18 February 2022
2 min
read
read
Briefings
Belgium Publishes Third Annual Report Regarding Screening of Foreign Direct Investment
11 September 2026